AI early warning for cancer spread
Part of Cancer clinical trials.
This trial uses artificial intelligence to predict if a cancer might spread to other parts of the body. It may help doctors catch metastasis earlier and improve treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with cancer (confirmed by a biopsy).
- Your cancer has not spread to other organs at the start of the study.
- You are scheduled for regular imaging tests (like CT or MRI) as part of your routine follow-up.
- Your complete medical records from diagnosis are available.
- You agree to let researchers use your imaging and medical data for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This study uses artificial intelligence to analyze tissue samples from breast cancer that has spread to distant organs, like the liver or lungs. The goal is to develop a tool that predicts how breast cancer might spread, helping doctors personalize treatment.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This study uses artificial intelligence to analyze your CT or MRI scans to see how well your tumor responds to treatment. It may help doctors better understand if your current treatment is working.
This study uses artificial intelligence to analyze electronic health records (including medical history, lab results, and imaging data) to improve cancer diagnosis and prediction. It aims to help identify cancer earlier and more accurately, potentially leading to better treatment outcomes.
Hear when a new Malignant Tumor With Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.